Processes for preparing zincoaluminosilicates with aei, cha, and gme topologies and compositions derived therefrom

A process for preparing a zincoaluminosilicate composition of CHA topology, the process comprising hydrothermally treating an aqueous composition comprising:

• (a) a source of a silicon oxide, and optionally a source of germanium oxide or combination thereof;
• (b) a source of aluminum oxide, and optionally a source of boron oxide, gallium oxide, hafnium oxide, iron oxide, tin oxide, titanium oxide, indium oxide, vanadium oxide, zirconium oxide, or combination or mixture thereof;
• and
• (c) a source of a zinc oxide;
• (d) a mineralizing agent;
• and
• (e) an organic structure directing agent (OSDA) comprising a trialkyladamantylammonium cation of Formula (II) or an optionally substituted trialkylbenzylammonium cation of Formula (III):
• under conditions effective to crystallize a crystalline microporous zincoaluminosilicate solid of CHA topology;
• wherein:
• R7, R8, and R9 are independently C1-6 alkyl or C1-3 alkyl;
• and wherein the quaternary trialkyladamantyl- or trialkylbenzyl-ammonium cation has an associated bromide, chloride, fluoride, iodide, nitrate, or hydroxide anion, and wherein
• the phenyl group of the trialkylbenzylammonium cation is optionally substituted with one to three fluoro or optionally fluorinated or perfluorinated C1-3 alkyl groups.

A composition comprising:

• (a) a source of a silicon oxide, and optionally a source of germanium oxide, or combination thereof;
• (b) a source of aluminum oxide, and optionally a source of boron oxide, gallium oxide, hafnium oxide, iron oxide, tin oxide, titanium oxide, indium oxide, vanadium oxide, zirconium oxide, or combination or mixture thereof;
• and
• (c) a source zinc oxide;
• (d) a mineralizing agent;
• (e) an organic structure directing agent (OSDA) comprising at least one isomer of the quaternary piperidinium cation of Formula (I):
• and
• (f) a compositionally consistent crystalline microporous zincoaluminosilicate solid of an AEI or GME topology;
• wherein
• RA and RB are independently a C1-3 alkyl, or together with the N to which they are bound form a 5 or 6 membered saturated or unsaturated ring;
• and
• R2, R3, R4, R5, and R6 are independently H or C1-3 alkyl, provided at least two of R2, R3, R4, R5, and R6 are independently C1-3 alkyl;
• and wherein
• the quaternary piperidinium cation has an associated bromide, chloride, fluoride, iodide, nitrate, or hydroxide anion.

A composition comprising:

• (a) a source of a silicon oxide, and optionally a source of germanium oxide or combination thereof;
• (b) a source of aluminum oxide, and optionally a source of boron oxide, gallium oxide, hafnium oxide, iron oxide, tin oxide, titanium oxide, indium oxide, vanadium oxide, zirconium oxide, or combination or mixture thereof;
• and
• (c) a source of a zinc oxide;
• (d) a mineralizing agent;
• (e) an organic structure directing agent (OSDA) comprising a trialkyladamantylammonium cation of Formula (II) or an optionally substituted trialkylbenzylammonium cation of Formula (III):
• and
• (f) a compositionally consistent crystalline microporous zincoaluminosilicate solid of a CHA topology wherein:
• R7, R8, and R9 are independently C1-6 alkyl or C1-3 alkyl;
• and wherein the quaternary trialkyladamantyl- or trialkylbenzyl-ammonium cation has an associated bromide, chloride, fluoride, iodide, nitrate, or hydroxide anion.

A crystalline microporous zincoaluminosilicate solid of GME or AEI topology having pores at least some of which are occluded with quaternary piperidinium cations of Formula (I):

• wherein
• RA and RB are independently a C1-3 alkyl, or together with the N to which they are bound form a 5 or 6 membered saturated or unsaturated ring;
• and
• R2, R3, R4, R5, and R6 are independently H or C1-3 alkyl, provided at least two of R2, R3, R4, R5, and R6 are independently C1-3 alkyl.

A crystalline microporous zincoaluminosilicate solid of CHA topology having pores at least some of which are occluded with a trialkyladamantylammonium cation of Formula (II) or an optionally substituted trialkylbenzylammonium cation of Formula (III):

• wherein:
• R7, R8, and R9 are independently C1-6 alkyl or C1-3 alkyl;
• wherein the quaternary trialkyladamantyl- or trialkylbenzyl-ammonium cation has an associated bromide, chloride, fluoride, iodide, nitrate or hydroxide anion;
• and wherein the phenyl group of the trialkylbenzylammonium cation is optionally substituted with one to three fluoro or optionally fluorinated or perfluorinated C1-3 alkyl groups.